Literature DB >> 7706502

Protection against endotoxic shock by bactericidal/permeability-increasing protein in rats.

H Jin1, R Yang, S Marsters, A Ashkenazi, S Bunting, M N Marra, R W Scott, J B Baker.   

Abstract

Bactericidal/permeability-increasing protein (BPI) is a neutrophil primary granule protein that inhibits effects of LPS in vitro. The current study examined the effects of BPI on hemodynamics, mortality, and circulating endotoxin and cytokines in conscious rats with endotoxic shock. Catheters were implanted into the right femoral artery and vein. 1 d later, human recombinant BPI (10 mg/kg) or vehicle was intravenously injected immediately, 30 min, or 2 h after intravenous injection of LPS (7.5 mg/kg). Mean arterial pressure (MAP) and heart rate were monitored and blood was collected before and after injection. BPI given immediately or 30 min after LPS prevented the LPS-induced reduction in MAP at 4-8 h and markedly reduced mortality. BPI given 2 h after LPS injection had no protective effect. BPI treated immediately after LPS reduced the circulating levels of endotoxin and IL-6 but increased the circulating levels of TNF. We propose that BPI exerts its protective effect through a TNF-independent mechanism, by inhibiting endotoxin-stimulated production of IL-6.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7706502      PMCID: PMC295740          DOI: 10.1172/JCI117877

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

Review 1.  Gram-negative bacillary infections. Pathogenic and pathophysiologic correlates.

Authors:  R J Duma
Journal:  Am J Med       Date:  1985-06-07       Impact factor: 4.965

Review 2.  Lipopolysaccharide nomenclature--past, present, and future.

Authors:  P J Hitchcock; L Leive; P H Mäkelä; E T Rietschel; W Strittmatter; D C Morrison
Journal:  J Bacteriol       Date:  1986-06       Impact factor: 3.490

3.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

4.  Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis.

Authors:  J L Shenep; K A Mogan
Journal:  J Infect Dis       Date:  1984-09       Impact factor: 5.226

5.  The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope.

Authors:  J Weiss; K Muello; M Victor; P Elsbach
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

6.  The role of bactericidal/permeability-increasing protein in the treatment of primate bacteremia and septic shock.

Authors:  M A Rogy; H S Oldenburg; S E Calvano; W J Montegut; S A Stackpole; K J Van Zee; M N Marra; R W Scott; J J Seilhammer; L L Moldawer
Journal:  J Clin Immunol       Date:  1994-03       Impact factor: 8.317

7.  Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure.

Authors:  J Weiss; S Beckerdite-Quagliata; P Elsbach
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

8.  Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.

Authors:  A Waage; A Halstensen; T Espevik
Journal:  Lancet       Date:  1987-02-14       Impact factor: 79.321

9.  Detection of endotoxin in the plasma of patients with gram-negative bacterial sepsis by the Limulus amoebocyte lysate assay.

Authors:  F C Pearson; J Dubczak; M Weary; G Bruszer; G Donohue
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

10.  Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia.

Authors:  D J Brackett; C F Schaefer; P Tompkins; L Fagraeus; L J Peters; M F Wilson
Journal:  Circ Shock       Date:  1985
View more
  9 in total

1.  Consequences of interaction of a lipophilic endotoxin antagonist with plasma lipoproteins.

Authors:  J R Rose; M A Mullarkey; W J Christ; L D Hawkins; M Lynn; Y Kishi; K M Wasan; K Peteherych; D P Rossignol
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  A synthetic lipopolysaccharide-binding peptide based on the neutrophil-derived protein CAP37 prevents endotoxin-induced responses in conscious rats.

Authors:  D J Brackett; M R Lerner; M A Lacquement; R He; H A Pereira
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  Bactericidal/permeability-increasing protein (rBPI21) and fluoroquinolone mitigate radiation-induced bone marrow aplasia and death.

Authors:  Eva C Guinan; Christine M Barbon; Leslie A Kalish; Kalindi Parmar; Jeff Kutok; Christy J Mancuso; Liat Stoler-Barak; Eugénie E Suter; Janice D Russell; Christine D Palmer; Leighanne C Gallington; Annie Voskertchian; Jo-Anne Vergilio; Geoffrey Cole; Kaya Zhu; Alan D'Andrea; Robert Soiffer; Jerrold P Weiss; Ofer Levy
Journal:  Sci Transl Med       Date:  2011-11-23       Impact factor: 17.956

4.  Role of the classical pathway of complement activation in experimentally induced polymicrobial peritonitis.

Authors:  I Celik; C Stover; M Botto; S Thiel; S Tzima; D Künkel; M Walport; W Lorenz; W Schwaeble
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

5.  Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes.

Authors:  Guangxun Meng; Mark Rutz; Matthias Schiemann; Jochen Metzger; Alina Grabiec; Ralf Schwandner; Peter B Luppa; Frank Ebel; Dirk H Busch; Stefan Bauer; Hermann Wagner; Carsten J Kirschning
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

6.  Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model.

Authors:  T Sawa; K Kurahashi; M Ohara; M A Gropper; V Doshi; J W Larrick; J P Wiener-Kronish
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

7.  Halobacterial nano vesicles displaying murine bactericidal permeability-increasing protein rescue mice from lethal endotoxic shock.

Authors:  Arjun Balakrishnan; Priya DasSarma; Oindrilla Bhattacharjee; Jong Myoung Kim; Shiladitya DasSarma; Dipshikha Chakravortty
Journal:  Sci Rep       Date:  2016-09-20       Impact factor: 4.379

8.  A Polymorphism of Bactericidal/Permeability-Increasing Protein Affects Its Neutralization Efficiency towards Lipopolysaccharide.

Authors:  Katharina U Ederer; Jonas M Holzinger; Katharina T Maier; Lisa Zeller; Maren Werner; Martina Toelge; André Gessner; Sigrid Bülow
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

9.  Pilot experience with opebacan/rBPI 21 in myeloablative hematopoietic cell transplantation.

Authors:  Eva Guinan; David E Avigan; Robert J Soiffer; Nancy J Bunin; Lisa L Brennan; Ilana Bergelson; Spencer Brightman; Al Ozonoff; Patrick J Scannon; Ofer Levy
Journal:  F1000Res       Date:  2015-12-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.